Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization
- 1 November 2021
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 26 (11) , 2743-2753
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
This publication has 66 references indexed in Scilit:
- Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance ResearchPLOS ONE, 2011
- Normalization of the Vasculature for Treatment of Cancer and Other DiseasesPhysiological Reviews, 2011
- Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancerCancer Chemotherapy and Pharmacology, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- Adaptive immunity maintains occult cancer in an equilibrium stateNature, 2007
- Reactive oxygen species and cellular oxygen sensingFree Radical Biology and Medicine, 2007
- Effect of heterogeneous vasculature on interstitial transport within a solid tumorMicrovascular Research, 2007
- VEGF/VEGFR signalling as a target for inhibiting angiogenesisExpert Opinion on Investigational Drugs, 2006
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971